Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)

NCT02808364 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Guangdong 999 Brain Hospital

Collaborators